Condition: Metabolic Syndrome (MetS) · Sponsor: Meihua Ji
The ENRICH study is aimed to Enpower patieNts with metabolic syndrome (Mets) to increase their Risk perception and to acquire health Information necessary for Capability building and promotion of Health information literacy, as well as health outcomes. The purpose of this clinical trial is to evaluate the efficacy of this health information literacy promotion intervention based on Health Empowerment Theory in individuals with metabolic syndrome. The study aims to answer the following questions: Does the intervention improve health information literacy among study participants? Does the intervention lead to better health outcomes, including weight, waist circumference, BMI control, and metabolic health indicators (blood pressure, blood glucose, glycated hemoglobin, and blood lipids)? Participants will: Undergo the intervention program for 6 weeks (face to face and online) and will be assessed regularly to monitor changes in terms of their level of health information literacy and health outcomes.
This description comes directly from the study's public registry record.
Meihua Ji · 86+15210434269 · Mjshouyi@ccmu.edu.cn
Always discuss trial participation with your own doctor first.
| Songzhuang Community Health Service Center | Beijing, Beijing Municipality, China | Recruiting |
| Yuqiao Subdistrict Community Health Service Center | Beijing, Beijing Municipality, China | Completed |
| Li Yuan Community Health Service Center in Tongzhou District, Beijing | Beijing, Beijing Municipality, China | Enrolling By Invitation |
| Lucheng Subdistrict Community Health Service Center | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07096102